Watch Closely (one)pentobarbital will decrease the extent or effect of buprenorphine subdermal implant by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Modify Therapy/Keep track of Carefully. Keep track of individuals currently on buprenorphine subdermal implant who demand recently-initiated cure with CYP3A4 inducer for signals and signs o